Evidence map›Paper›PMID 29100394›Full record

ArticleOncotarget2017

Effects of photodynamic therapy on dermal fibroblasts from xeroderma pigmentosum and Gorlin-Goltz syndrome patients.

Alicia Zamarrón, Marta García, Marcela Del Río, Fernando Larcher, Ángeles Juarranz

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Daylight Photodynamic Therapy: An Update.Molecules (Basel, Switzerland) · 2020
    Review
  7. Review
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Alicia ZamarrónDepartment of Biology, Faculty of Sciences, Autónoma University of Madrid, IRYCIS, Madrid, Spain.
Marta GarcíaDepartment of Bioengineering, Carlos III University (UC3M), Madrid, Spain.
Marcela Del RíoDepartment of Bioengineering, Carlos III University (UC3M), Madrid, Spain.
Fernando LarcherDepartment of Bioengineering, Carlos III University (UC3M), Madrid, Spain.
Ángeles JuarranzDepartment of Biology, Faculty of Sciences, Autónoma University of Madrid, IRYCIS, Madrid, Spain.
Universidad Autónoma de Madrid · ESCentre for Biomedical Network Research on Rare Diseases · ESCentro de Investigaciones Energéticas, Medioambientales y Tecnológicas · ESHospital Universitario Fundación Jiménez Díaz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PDT is widely applied for the treatment of non-melanoma skin cancer pre-malignant and malignant lesions (actinic keratosis, basal cell carcinoma and

Indexed as

cancer-associated fibroblastsGorlin-Goltz syndromephotodynamic therapyultraviolet lightxeroderma pigmentosum

Identifiers

PMID29100394
PMCPMC5652786
OpenAlexW2749684155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.